Clinical Trial

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2025 (before its estimated June 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the effect of administration of folic acid and /or pentoxifylline on patients with chronic kidney disease (CKD).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-03-09; most recent amendment 2025-06-10.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-06-10
Trial Details
NCT Number NCT05284656
Lead Sponsor Al-Azhar University
Conditions Chronic Kidney Diseases
Enrollment 80 participants
Start Date 2022-01-08
Primary Completion 2026-06-12 (estimated)
Study Completion 2026-12-19 (estimated)
Updated on ClinicalTrials.gov 2025-06-11